“The Association Between Immune-Histochemical Expressions of Program Death Ligand With Some Aggressive Features of Prostate Cancer”. Al-Nahrain Journal of Science 27, no. 2 (June 15, 2024): 63–67. Accessed April 5, 2025. https://anjs.edu.iq/index.php/anjs/article/view/2653.